Helsingborg, Sweden

Fredrik Björkling

This inventor holds 2 USPTO granted patents. Top assignees: Leo Pharmaceuticals Products Ltd. A/s, Other. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fredrik Björkling. Retrieved from https://idiyas.com/inventor/fredrik-bjandoumlrkling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fredrik Björkling: Innovator in Vitamin D Analogues

Introduction

Fredrik Björkling is a notable inventor based in Helsingborg, Sweden. He has made significant contributions to the field of neuroscience through his innovative work on vitamin D analogues. With a total of two patents to his name, Björkling's research focuses on the neuronal effects of these compounds.

Latest Patents

His latest patents include "Aminobenzophenones - Vitamin D analogues and their neuronal effects." This invention is directed towards methods of utilizing low calcemic vitamin D analogues. Specifically, it aims to treat neurodegenerative diseases and disorders, facilitate the endogenous production of neurotrophic factors, inhibit the degradation, dysfunction, or loss of neural cells, and enhance the phenotype of neural cells or neuronal processes.

Career Highlights

Throughout his career, Björkling has worked with various companies, including Leo Pharmaceuticals Products Ltd. His work has been instrumental in advancing the understanding of vitamin D's role in neural health.

Collaborations

Fredrik has collaborated with professionals such as Susan Carswell and Pawel Dobrzanski, contributing to a rich exchange of ideas and expertise in his field.

Conclusion

Fredrik Björkling's innovative work on vitamin D analogues highlights his commitment to addressing neurodegenerative diseases. His contributions continue to pave the way for advancements in neuroscience and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…